REFERENCES
1. Specialised Commissioning Team NE. Hand and upper limb reconstruction using vascularised composite allotransplantation (HAUL-VCA). Available from: https://www.england.nhs.uk/wp-content/uploads/2018/07/Hand-and-upper-limb-reconstruction-using-vascularised-composite-allotransplantation.pdf [Last accessed on 16 Mar 2023].
2. Roșca AC, Baciu CC, Burtăverde V, Mateizer A. Psychological consequences in patients with amputation of a limb. An interpretative-phenomenological analysis. Front Psychol 2021;12:537493.
3. Resnik L, Borgia M, Clark M. Function and quality of life of unilateral major upper limb amputees: effect of prosthesis use and type. Arch Phys Med Rehabil 2020;101:1396-406.
4. Efanov JI, Tchiloemba B, Izadpanah A, Harris PG, Danino MA. A review of utilities and costs of treating upper extremity amputations with vascularized composite allotransplantation versus myoelectric prostheses in Canada. JPRAS Open 2022;32:150-60.
5. Blough DK, Hubbard S, McFarland Lv, Smith DG, Gambel JM, Reiber GE. Prosthetic cost projections for servicemembers with major limb loss from vietnam and OIF/OEF. J Rehabil Res Dev 2010;47:387-402.
6. Wartan SW, Hamann W, Wedley JR, Mccoll I. Phantom pain and sensation among British veteran amputees. Br J Anaesth 1997;652:121-9.
7. Hsu E, Cohen SP. Postamputation pain: epidemiology, mechanisms, and treatment. J Pain Res 2013;6:121-36.
8. Collins KL, Russell HG, Schumacher PJ, et al. A review of current theories and treatments for phantom limb pain. J Clin Invest 2018;2168:121-76.
9. Kim M, Kim Y, Ryu GW, Choi M. Functional status and health-related quality of life in patients with peripheral artery disease: a cross-sectional study. Int J Environ Res Public Health 2021;18:10941.
11. Dumanian GA, Potter BK, Mioton LM, et al. Targeted muscle reinnervation treats neuroma and phantom pain in major limb amputees: a randomized clinical trial. Ann Surg 2019;270:238-46.
12. Souza JM, Cheesborough JE, Ko JH, Cho MS, Kuiken TA, Dumanian GA. Targeted muscle reinnervation: a novel approach to postamputation neuroma pain. Clin Orthop Relat Res 2014;472:2984-90.
13. Kang NV, Woollard A, Michno DA, Al-Ajam Y, Tan J, Hansen E. A consecutive series of targeted muscle reinnervation (TMR) cases for relief of neuroma and phantom limb pain: UK perspective. J Plast Reconstr Aesthet Surg 2022;75:960-9.
14. NICE. Position statement on use of the EQ-5D-5L value set for England (updated October 2019). Available from: https://www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance/technology-appraisal-guidance/eq-5d-5l [Last accessed on 16 Mar 2023].
15. Ernstsson O, Hagberg K, Janssen MF, Bonsel GJ, Korkmaz S, Zethraeus N, et al. Health-related quality of life in patients with lower limb amputation-an assessment of the measurement properties of EQ-5D-3L and EQ-5D-5L using data from the Swedish Amputation and Prosthetics Registry. Disabil Rehabil 2022;44:8471-9.
16. Vakhshori V, Bouz GJ, Mayfield CK, Alluri RK, Stevanovic M, Ghiassi A. Trends in pediatric traumatic upper extremity amputations. Hand 2019;14:782-90.
17. Bullinger M, Quitmann J. Quality of life as patient-reported outcomes: principles of assessment. Dialogues Clin Neurosci 2014;16:137-45.
